Skip to main content
NACFC 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Session includes invitee/speaker with CF
Session includes invitee/speaker with CF
Livestreamed Session
Livestreamed Session
Recorded Session
Recorded Session
Session is Ticketed (Must Register for Session through Registration)
Session is Ticketed (Must Register for Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees

APPTT
Session Type: Rapid-Fire Poster Talk

RFPT01--Therapeutic Targeting of Inflammation in CF

Thursday, October 23, 2025
9:00 AM - 9:50 AM PDT
Location:Theater B Exhibit Hall

Attendees will learn the latest novel science tackling pathways of aberrant inflammation in people with cystic fibrosis, using a variety of model systems. Session will feature rapid fire poster talks and interactive discussions.

Presentations:

  • 9:00 AM - 9:50 AM PDT
    RFPT01.1- Chronic lung inflammation in CF drives maladaptive trained Tmmunity in hematopoietic stem cells

    Speaker: Cassia Braga, PhD – Yale School of Medicine

  • 9:00 AM - 9:50 AM PDT
    RFPT01.2- IL-21 and IL-21R interaction plays a key role in mounting humoral and cell-mediated immune response to adenoviral and adeno-associated viral vectors in lung

    Speaker: Mina R. Hanna, MD, MS – Tulane University School of Medicine

  • 9:00 AM - 9:50 AM PDT
    RFPT01.3- Targeting microRNAs as anti-inflammatory therapeutics for CF lung disease

    Speaker: Roopa Biswas, Ph.D. – Uniformed Services University

  • 9:00 AM - 9:50 AM PDT
    RFPT01.4- PDE4 inhibitor apremilast rebalances inflammatory responses to Pseudomonas aeruginosa infection in CF rats

    Speaker: Linto Antony, PhD – University of Alabama at Birmingham

  • 9:00 AM - 9:50 AM PDT
    RFPT01.5- Assessing infection and inflammation in CF through exhaled breath: A longitudinal study

    Speaker: Josephine Ackah-Cudjoe, MSc – University of British Columbia

  • 9:00 AM - 9:50 AM PDT
    RFPT01.6- KIT2014, a clinical-stage inhaled PDE3/4 inhibitor to target airway neutrophilic inflammation and CFTR dysfunction.

    Speaker: Valentina Sala, PhD – Kither Biotech

  • 9:00 AM - 9:50 AM PDT
    RFPT01.7- Long term effects of elexacaftor/tezacaftor/ivacaftor on airway and systemic inflammation in CF over a five-year period

    Speaker: Eamon Maurice Mullen, N/A, MBBCHBAO – Royal college of surgeons in Ireland

  • 9:00 AM - 9:50 AM PDT
    RFPT01.8- Effects of environmental and social epidemiological factors on cytokine response in people with CF

    Speaker: Maria Ansar, MD-PhD – Cincinnati Children's Hospital Center